Skip to Main Content (Press Enter)
×
Home
Corsi
Insegnamenti
Persone
Pubblicazioni
Attività
Competenze
IT
EN
☰
UNI-FIND
|
UNI-FIND
unicatt.it
IT
EN
×
Home
Corsi
Insegnamenti
Persone
Pubblicazioni
Attività
Competenze
☰
Pubblicazioni
EXPERT OPINION ON BIOLOGICAL THERAPY
Rivista
Codice:
E061650
ISSN:
1471-2598
Dati Generali
Dati Generali
Pubblicazioni (41)
Pulisci
Ordina Pubblicazioni:
ascendente
decrescente
A Randomized Blinded Retrospective Study: the combined use of Micro-needling Technique, Low-Level Laser Therapy and Autologous Non-Activated Platelet-Rich Plasma improves Hair Re-Growth in patients with Androgenic Alopecia
Articolo
A new class of biologic agents facing the therapeutic paradigm in psoriasis: Anti-IL-23 agents
Articolo
Actoxumab + bezlotoxumab combination: what promise for Clostridium difficile treatment?
Articolo
Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis
Articolo
Adipose-derived stem cell therapies for bone regeneration
Articolo
An up-to-date review of approved and emerging antibody therapies for idiopathic pulmonary fibrosis
Articolo
Antibody-based therapies for idiopathic pulmonary fibrosis
Articolo
Antibody-based therapies for idiopathic pulmonary fibrosis
Articolo
Autologous activated platelet-rich plasma (AA-PRP) and non-activated (A-PRP) in hair growth: a retrospective, blinded, randomized evaluation in androgenetic alopecia
Articolo
Biological agents targeting interleukin-13 for atopic dermatitis
Articolo
Cancer stem cells: the development of new cancer therapeutics
Articolo
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study
Articolo
Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature
Articolo
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy
Articolo
Comparison of short- and long-term effectiveness of ixekizumab and secukinumab in real-world practice
Articolo
Cord blood transplantation for acute leukemia
Articolo
Current treatment goals are achieved by the majority of patients with atopic dermatitis treated with tralokinumab: results from a multicentric, multinational, retrospective, cohort study
Articolo
Fecal transplantation for ulcerative colitis: current evidence and future applications
Articolo
Head and neck atopic dermatitis: still a challenging manifestation in the biologic era
Articolo
High-resolution mass spectrometry for thymosins detection and characterization
Articolo
How far are we from the clinical use of placental-derived mesenchymal stem cells?
Articolo
Identification of PDGF-BB binding to thymosin β4 by chemical cross-linking
Articolo
Immunogenicity of anti-TNFα therapy in psoriasis: a clinical issue?
Articolo
One-year effectiveness and safety of ustekinumab in ulcerative colitis: a multicenter real-world study from Italy
Articolo
Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in Italy
Articolo
Real-life experience with ixekizumab in plaque psoriasis: a multi-center, retrospective, 3-year study
Articolo
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn's disease: results from an Italian multicenter study
Articolo
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year
Articolo
Regenerative application of stromal vascular fraction cells enhanced fat graft maintenance: clinical assessment in face rejuvenation
Articolo
Risankizumab for the treatment of moderate to severe psoriasis
Articolo
Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation
Articolo
Successes and failures: the latest advances in the clinical development of amyloid–β–targeting monoclonal antibodies for treating Alzheimer's disease
Articolo
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients
Articolo
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients
Articolo
The potential of solanezumab and gantenerumab to prevent Alzheimerâ s disease in people with inherited mutations that cause its early onset
Articolo
Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases
Articolo
Thymosin fraction 5 re-evaluated after 35 years by high-resolution mass spectrometry.
Articolo
Tildrakizumab for treatment of moderate to severe psoriasis: an expert opinion of efficacy, safety, and use in special populations
Articolo
Use of brodalumab for the treatment of chronic plaque psoriasis: a one-year real-life study in the Lazio region, Italy
Articolo
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers
Articolo
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study
Articolo
No Results Found
«
‹
{pageNumber}
›
»
{startItem} - {endItem} di {itemsNumber}
5 per pagina
10 per pagina
30 per pagina
vedi tutti
